CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Entecavir

Last Updated: December 12, 2006
Result type: Reports
Project Number: S0089
Product Line: Reimbursement Review

Generic Name: Entecavir

Brand Name: Baraclude

Manufacturer: Bristol-Myers Squibb Canada

Therapeutic Area: Hepatitis B (chronic)

Indications: Hepatitis B (chronic)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: November 28, 2007

Recommendation Type: List with clinical criteria and/or conditions